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Abstract: Cardiac markers play an important role in prognosis and follow-up treatment. Therefore, it is of great
practical significance to study the detection methods of high-sensitivity C-reactive protein cardiac markers. The purpose
of this paper is to study the optimal method for the detection of cardiac markers of high-sensitivity C-reactive protein.
In this paper, the significance of cardiac markers and high-sensitivity C-reactive protein and the relationship between
them and myocardial infarction were first described. The BCA method for the purification and identification of
C-reactive protein was studied, and then the determination and optimization of high-sensitivity C-reactive protein and
high-sensitivity C-reactive protein in healthy people were further understood. To explore the application of serum high
sensitive C-reactive protein in the detection of cardiac markers in 50 patients with acute myocardial infarction and 50
healthy people. The results showed that the experimental group was (21.57 ± 1.50), (37.62 ± 1.66), (529.20 ± 5.72),
(95.79 ± 6.24) ng / ml, the control group was (0.90 ± 1.10), (1.71 ± 0.14), (35.25 ± 4.21), (0.99 ± 0.71) ng / ml, and the
difference between the two groups was statistically significant (P < 0.05).
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1. Introduction
CRP production is related to the stimulation of other
inflammatory factors[1-3]. When the structure damage,
microorganism entry, antibody reaction, stress reaction
and malignant tumor can stimulate the rapid increase of
C-reactive protein synthesis, so that the concentration of
C-reactive protein increases thousands of times. It is a
globulin with molecular weight of 1-140 KD[4-5]. If CRP
continues to rise, it indicates chronic inflammation,
which may also be caused by autoimmune diseases[6].
The increase of hs CRP in blood is a useful predictor of
near and peripheral vascular diseases. Although there is a
close relationship between blood lipid and coronary heart
disease, nearly 50% of patients with myocardial
infarction have no hyperlipidemia, which is a common
mechanism difficult to explain[7-9]. Cardiac markers are
also significant in evaluating prognosis and follow-up
treatment. Therefore, it is of great practical significance
to study the detection methods of high-sensitivity
C-reactive protein cardiac markers.
Sujaya Gupta study assessed CRP levels in patients
with and without periodontitis and their relationship to
BMI and smoking behavior. Serum CRP was
taken before periodontal treatment, and SPSS 17
software was used for data analysis. Results: the mean
level of CRP (5.8595mg / L) in periodontitis group was
significantly higher than that in non periodontitis group
(1.1214mg / L)
Copyright © 2020 Chen Dai
doi: 10.18686/aem.v9i1.157
This is an open-access article distributed under the terms of the Creative CommonsAttribution Non-Commercial License
(http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,
provided the original work is properly cited.
10 | Chen Dai Advanced Emergency Medicine
(P = 0.000). BMI and CRP had no correlation, but they
were related to periodontitis. There was no significant
relationship between smoking behavior and CRP (P =
0.344) and periodontitis (P = 0.541). They found a highly
significant correlation between periodontitis and CRP
levels, but not always with BMI and smoking. CRP was
significantly increased in periodontal infection and was a
marker of CVD. Therefore, it is recommended that
doctors, periodontists and patients interact closely to
prevent adverse health conditions[10]. Jonathan Buggey
found that higher epicardial fat levels may be related to
the duration of antiretroviral therapy and chronic
inflammation, but not to other indicators of obesity, such
as body mass index. They are associated with increased
coronary calcium, myocardial perfusion defects, death,
and myocardial infarction. The association with risk
may be partly mediated by the direct action of cytokines
and adipokines produced by adipose tissue. In addition,
the increase of myocardial fat deposition in HIV infected
patients is also related to the time of antiretroviral
therapy[11]. Beata Moczulska studied pulse wave velocity
(PWV) in patients with congestive heart failure and
hypertension. The arterial hardness was measured by
Mobil-O-Graph NG-PWA, and the pulse velocity (PWV)
was estimated. Results: PWV in DHF group was
significantly higher than that in control group. The
average E / a value of heart failure group was
significantly lower than that of non heart failure group.
Conclusion: the oscillographic measurement of pulse
wave velocity is noninvasive and lasts for several
minutes without the presence of experts. Even in primary
health care, patients at risk of diastolic heart failure
can be identified early[12].
In this paper, the significance of cardiac markers
and high-sensitivity C-reactive protein and the
relationship between them and myocardial infarction
were first described. The BCA method for the
purification and identification of C-reactive protein was
studied, and then the determination and optimization of
high-sensitivity C-reactive protein and high-sensitivity
C-reactive protein in healthy people were further
understood. In this paper, 50 patients with acute
myocardial infarction and 50 healthy people were
selected to study the application of serum
high-sensitivity C-reactive protein in the detection of
cardiac markers. The experimental results showed that
troponin was a marker of myocardial infarction.
Troponin increased in 3-5 hours, peaked in 13-37 hours
and lasted for 9 days. Its sensitivity is as high as 96%.
2. Proposed method
2.1 Heart markers
Seven million people die of cardiovascular disease
every year. Cardiac markers have a good diagnostic
effect on cardiovascular diseases. Because some cardiac
markers are not widely used, it is urgent to strengthen the
promotion of diagnostic methods of cardiac markers.
Cardiac markers, such as troponin, fatty
acid binding protein and ischemia modified albumin
(IMA), are also significant in evaluating prognosis and
follow-up treatment.
2.2 Purification and identification of
C-reactive protein
1) Determination of protein concentration by BCA
2) Preparation of standard curve sample: BSA
2.0mg/ml was diluted with PBS.
3) Add the sample collection solution into the
enzyme plate and the working solution respectively,
shake and mix well, then read the od595nm data through
the enzyme reader, and calculate the concentration of
each tubulin through the standard curve.
2.3 Hypersensitive C-reactive protein
Hypersensitive C-reactive protein and C-reactive
protein belong to the same kind of protein. The
difference between them is that the measured data of
hypersensitive C-reactive protein is much higher than
that of C-reactive protein. The principle of
immunoenhancement turbidimetry was used for the
detection of hypersensitive C-reactive protein, and the
detection limit of CRP was more than 3-5mg · L-1 by
immunotransmission turbidimetry or immunoscattering
turbidimetry. In the presence of inflammation, the serum
CRP level peaked 24-48 hours later, and the serum CRP
level recovered to normal soon after inflammation
elimination, with a half-life of 4-7 hours. The use of CRP
in acute myocardial infarction and trauma and infection,
and in surgery and cancer can significantly increase
infiltration. Because CRP is not a stable characteristic, it
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has high value in infectious diseases and connective
tissue diseases. Through the discovery of cardiovascular
events, it is necessary to exclude the injury of tissues,
inflammation, tumor and infection in human body, and
then measure the level of hs CRP. Hs CRP, as an acute
reactive protein of IL-6, TNF and other cytokines, is an
independent risk factor of coronary heart disease. It is
generally considered that hs CRP < 1.0mg · L-1 is of low
risk, 1.0-3.0mg · L-1 is of moderate risk and >
3.0mg · L-1 is of moderate risk. It is highly dangerous.
Serum 40-160mg · L-1 in patients with myocardial
infarction, the phenomenon of unstable angina will be
higher gradually, and stable angina is also normal.
Although CRP as a precursory target of coronary heart
disease is supported, the increasing CRP data will be
involved in the formation of atherosclerotic plaque,
which will cause the phenomenon of unstable plaque
rupture, which may be the sensitive index of
inflammation.
(1) Hypersensitive C-reactive protein in healthy
people
In general, hs CRP can detect the level of
inflammation less than 0.20mg/l. The low level of
inflammation detection has an important value in judging
coronary heart disease, cerebrovascular disease and its
risk.
(2) Determination and optimization of high
sensitive C-reactive protein
Latex enhanced immunoturbidimetric method was
used to improve the sensitivity and the accuracy in the
low concentration range. High precision and reliability
are required. Early agglutination is no longer used in
most hospitals because of its poor accuracy.
Immunoturbidimetry (including scattering method and
transmission method) is also difficult to meet the
requirements of hypersensitivity.
3. Experiments
3.1 Experimental data set
From September 2018 to March 2019, 501 patients
were admitted to the Department of Cardiology.
According to the inclusion criteria and exclusion criteria,
306 patients were selected. All patients passed the
examination. There were 206 patients in the myocardial
infarction group, including 100 males and 109 females,
all of whom were 50.47 ± 8.32 years old. 206 patients in
the control group, including 105 males and 104 females,
had the same average age at 47.21 ± 9.97 years old, all
patients had no other serious diseases. At the time of
admission, each patient was inquired about the detailed
medical history by the cardiologist and recorded the
information including the age, gender, smoking, drinking,
history of hypertension and diabetes to be investigated;
each patient was examined carefully by the cardiologist,
including: blood pressure level, weight, etc. Each patient
underwent ECG and venous blood sampling 24 hours
after hospitalization. The contents of blood examination
include: blood routine, aging of liver and kidney, changes
of blood glucose, blood lipid, hs CRP, C1q and uric acid.
3.2 Detection of serum hs CRP
In this study, the value of hs CRP in the two groups
of patients was detected by immunoturbidimetry, and
the 7600 automatic biochemical analyzer, which was
mainly equipped in the laboratory of hospital, was used
as the measuring instrument for the micro quantitative
detection of hs CRP. The high sensitive C-reactive
protein reagent produced by Dade Behring Marburg
GmbH was used for determination. The normal reference
value range provided by the laboratory of the people's
hospital was 0-2.1mg/l. According to the manual and the
quality control system, double standard and double tube
measurement methods were used. Finally, the hs CRP
values of three groups of patients were statistically
analyzed.
3.3 Instruments and equipment
Rt-2100c;
Constant temperature water bath box;
Hitachi 7170A automatic biochemical analyzer;
Kdc-40 medium and low speed centrifuges from
Zhongjia, HKUST;
Medical dw-86w420 low temperature refrigerator;
Siemens axidm artis DFA X-ray angiography
system;
Lead-7000 multichannel physiological recorder.
3.4 Statistical methods
All data are processed and analyzed by scientific
statistical software. In this study, spssl9.0 software and
X2 test method are used to calculate all counting data. If
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the results are statistically significant, the difference
will be more obvious.
4. Discussion
4.1 Comparison of isoenzyme concentration
of cardiac markers between the two groups
The concentrations of high-sensitivity C-reactive
protein, troponin I, myoglobin and creatine kinase
isoenzyme in the experimental group were (529.20 ±
5.72), (95.79 ± 6.24) ng / ml, respectively, and those in
the control group were (0.90 ± 1.10), (1.71 ± 0.14),
(35.25 ± 4.21), (0.99 ± 0.71) ng / ml. the
differences between the two groups were not
significant but significant (P < 0.05), as shown in Table
1.
The results showed that the concentration of cardiac
marker isoenzyme in the experimental group was
significantly higher than that in the control group (P <
0.05), suggesting that there was a positive
correlation between myocardial infarction and cardiac
marker isoenzyme. Through the simultaneous detection
of the four, we can find the early symptoms of
myocardial infarction, which is very important for early
diagnosis. However, the level of myoglobin in
human body will gradually increase 3 hours after the
onset of the disease, but the rejection to the heart is not
high, and it is a marker of myocardial injury (generally
speaking, the symptoms occur within 7 hours, and the
level of myoglobin in the blood will gradually increase).
However, we can find that another damage will be
creatine kinase isoenzyme. The activity of this enzyme is
related to the location, area and prognosis of myocardial
infarction. This enzyme has been used as a marker of
myocardial injury, but its flexibility is not high, its
discrimination is poor, it is difficult to distinguish from
skeletal muscle disease and injury, it is difficult to
diagnose small myocardial infarction, often
false-positive and false negative, it can not be used alone
in clinical.
Hypersensitive
C-reactive protein
Troponin I Myoglobin Creatine kinase
Test group 21.57±1.50 ng/ml 37.62±1.66 ng/ml 529.20±5.72 ng/ml 95.79±6.24 ng/ml
Control group 0.90±1.10 ng/ml 1.71±0.14 ng/ml 35.25±4.21 ng/ml 0.99±0.71 ng/ml
Table 1. Comparison of isoenzyme concentrations between the two groups
4.2 Comparison of the positive rate of
cardiac marker isoenzyme between the two
groups
The positive rates of high-sensitivity C-reactive
protein, troponin I, myoglobin and creatine kinase
isoenzyme in the experimental group were 83%, 78%,
and 49%, respectively, while those in the control group
were 5%, 0%, 0%, 0% and 0%, respectively. The positive
rates of cardiac marker isoenzyme were statistically
significant (P < 0.05), as shown in Figure 1.
Figure 1. Comparison of isozyme positive rates between the two groups.
Troponin is a marker of myocardial infarction.
Troponin increased in 3-5 hours, peaked in 13-37 hours
and lasted for 9 days. Its sensitivity is 96% and
specificity is 99%. It is the best marker of myocardial
infarction. The influence of cardiac markers and high
sensitive CRP in patients with acute myocardial
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infarction will lead to the occurrence of the disease. The
results of high sensitive CRP in patients with acute
myocardial infarction were more than 8, which exceeded
the normal index. This may be due to the abnormal
cardiac markers, resulting in the increase of CRP test
results. The increase of CRP can cause acute
inflammatory reaction, and form cardiovascular
atherosclerosis and acute myocardial infarction.
5. Conclusions
In this paper, 50 patients with acute myocardial
infarction and 50 healthy people were selected to study
the application of serum high-sensitivity C-reactive
protein in the detection of cardiac markers. Through the
study of CRP, the experimental group was (21.57 ± 1.50),
(37.62 ± 1.66), (529.20 ± 5.72), (95.79 ± 6.24) ng / ml,
the control group was (0.90 ± 1.10), (1.71 ± 0.14), (35.25
± 4.21), (0.99 ± 0.71) ng / ml, and the difference between
the two groups was statistically significant (P < 0.05).
The abnormality of cardiac markers was observed, and
the effect of CRP level change on the condition was
analyzed to a certain extent. It was also an acute heart
disease Main monitoring items of patients with
myocardial infarction.
References
1. Laura CT, Eliana M, María S, et al. Detection of
reactive oxygen and nitrogen species (ROS/RNS)
during hypersensitive cell death. Plant Programmed
Cell Death 2018; 116(6): 97-105. doi:
10.1007/978-1-4939-7668-3_9.
2. Masayuki T. High-sensitive C-reactive protein in
primary aldosteronism. Journal of Hypertension
2017; 35(1): 200.
doi:10.1097/HJH.0000000000001163.
3. Reihane J, Elham K. Level of high sensitive
C-reactive protein and procalcitonin in pregnant
women with mild and severe preeclampsia.
Advanced Biomedical Research 2017; 6(1): 140.
doi: 10.4103/2277-9175.218032.
4. Luigi R, Nick AB, Antoine M. Ultra-high sensitive
C-reactive protein during normal pregnancy and in
preeclampsia: a pilot study. Journal of Hypertension
2019; 37(5): 1. doi:
10.1097/HJH.0000000000002003.
5. L. Ziyun, L. Bo, J. Ye. Association between serum
uric acid levels and high sensitive C-reactive
protein in patients with type 2 diabetes. Zhonghua
Yi Xue Za Zhi 2017; 97(28): 2181-2185. doi:
10.3760/cma.j.issn.0376-2491.2017.28.005.
6. Boyapati R, Chinthalapani S, Ramisetti A, et al.
Association of pentraxin and high-sensitive
C-reactive protein as inflammatory biomarkers in
patients with chronic periodontitis and peripheral
arterial disease. Journal of Indian Society of
Periodontology 2018; 22(2): 112-115.
7. Aidin L, Behzad E. The role of supplements in
reducing cardiovascular events by decrease in
highly sensitive C-reactive protein and serum
homocysteine. Saudi Journal of Kidney Diseases &
Transplantation 2017; 28(6): 1451. doi:
10.4103/1319-2442.220853.
8. Kaur M. C-reactive protein: A prognostic indicator.
International Journal of Applied & Basic Medical
Research 2017; 7(2): 83-84. doi:
10.4103/ijabmr.IJABMR_63_17.
9. Dimitrios V, Nikolaos P, Ioanna K. C-reactive
protein and frailty in the elderly: A literature review.
Journal of Clinical Medicine Research 2017; 9(6):
461-465. doi: 10.14740/jocmr2959w.
10. Sujaya G, Shaili P, Sushil K. C-reactive protein in
periodontitis and its comparison with body mass
index and smoking behaviour. Journal of the Nepal
Medical Association 2017; 55(206): 226-233. doi:
10.31729/jnma.3134.
11. Jonathan B, Chris TL. Heart fat in HIV: Marker or
mediator of risk?. Current Opinion in Hiv & Aids
2017; 12(6): 1. doi:
10.1097/COH.0000000000000414.
12. Moczulska B, Kubiak M, Bryczkowska A, et al.
Pulse wave velocity as an early marker of diastolic
heart failure in patients with hypertension. Polski
Merkuriusz Lekarski Organ Polskiego 2017;
42(250): 142-144.
